STERIS plc (STE) stock analysis
STE · STERIS plc
Latest recorded price: USD 261.91
Model-estimated fair value: USD 138.64. This assumption-based estimate is for general research and is not investment advice.
Sector and industry: Healthcare · Medical Devices
At $261.91, STE trades 88.9% above the model's base-case value of $138.64. Using Operating FCFF DCF (revenue x margin - reinvestment), the model estimates $109.02 in the conservative case and $171.84 in the optimistic case, with a valuation confidence score of 45/100. About 74% of the value comes from the terminal value, so the result is sensitive to long-term growth and discount-rate assumptions. Fiscal 2026 figures: revenue growth 6.2%, free cash flow margin 16.4%, ROIC 10.1%. The model does not flag any risk signals for this company.